Cargando…
Early Immunosuppressive Exposure of Enteric-Coated-Mycophenolate Sodium Plus Tacrolimus Associated with Acute Rejection in Expanded Criteria Donor Kidney Transplantation
BACKGROUND: Immunosuppressive agents are still inefficient in preventing biopsy-proven acute rejection (BPAR) after expanded criteria donor (ECD) kidney transplantation. The aim of this study was to investigate the relationships between early immunosuppressive exposure and the development of BPAR. M...
Autores principales: | Ding, Chen-Guang, Jiao, Li-Zi, Han, Feng, Xiang, He-Li, Tian, Pu-Xun, Ding, Xiao-Ming, Pan, Xiao-Ming, Tian, Xiao-Hui, Li, Yang, Zheng, Jin, Xue, Wu-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987500/ https://www.ncbi.nlm.nih.gov/pubmed/29786042 http://dx.doi.org/10.4103/0366-6999.232797 |
Ejemplares similares
-
Long-Term Results of Triple Immunosuppression With Tacrolimus Added to Mycophenolate and Corticosteroids in the Treatment of Lupus Nephritis
por: Yap, Desmond Y.H., et al.
Publicado: (2021) -
Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
por: Dalal, P, et al.
Publicado: (2010) -
A four-drug combination therapy consisting of low-dose tacrolimus, low-dose mycophenolate mofetil, corticosteroids, and mizoribine in living donor renal transplantation: A randomized study
por: Yan, Tian-zhong, et al.
Publicado: (2016) -
Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
por: Kim, Hyeyoung, et al.
Publicado: (2014) -
Improved Gastrointestinal Symptoms and Quality of Life after Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients Receiving Tacrolimus
por: Hwang, Hyeon Seok, et al.
Publicado: (2010)